Paracetamolo e vigile attesa”? Raccomandazione rovinosa

Raccomandazione rovinosa

BIBLIOGRAFIA ARTICOLO PUBBLICATO SUL N. 148

1. Circolare Ministero della Salute n. 24970 del 30 Novembre 2020 – Certifico Srl
2. Circolare Ministero Salute 26 aprile 2021 – Certifico Srl
3. RCP_002745_030524 (2).pdf
4. Roberts E., Delgado Nunes V., Buckner S., et al.Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis. 2016 Mar;75(3):552-9. doi: 10.1136/annrheumdis-2014-206914
5. Kaur J, Nakafero G, Abhishek A, et al. Incidence of Side Effects Associated With Acetaminophen in People Aged 65 Years or More: A Prospective Cohort Study Using Data From the Clinical Practice Research Datalink. Arthritis Care Res (Hoboken). 2025 May;77(5):666-675. doi: 10.1002/acr.25471.
6. WHO. Home care for patients with suspected or confirmed COVID-19 and management of their contacts: interim guidance, 12 August 2020
7. WHO. 5 STEPS for Managing patients with COVID-19 at home: For the public. managing-patient-5steps-public.pdf
8. WHO. For the Public. MANAGING COVID-19 AT HOME: What medicines to take (and not take). medicine-for-public_final-3-june_v3.pdf
9. COVID-19 early treatment: real-time analysis of 5,659 studies
10. Choudhury et al. Effect of 1% Povidone Iodine Mouthwash/Gargle, Nasal and Eye Drop in COVID-19 patient. Bioresearch Communications. Dec 2020 doi:10.3329/brc.v7i1.54245.
11. Amici C, Di Caro A, Ciucci A, et al. Indomethacin has a potent antiviral activity against SARS coronavirus. Antivir Ther. 2006;11(8):1021-30.
12. Little P, Moore M, Kelly J, et al. Ibuprofen, paracetamol, and steam for patients with respiratory tract infections in primary care: pragmatic randomised factorial trial. BMJ. 2013 Oct 25;347:f6041. doi: 10.1136/bmj.f6041.
13. Little P, Stuart B, Andreou P, et al. Primary care randomised controlled trial of a tailored interactive website for the self-management of respiratory infections (Internet Doctor). BMJ Open. 2016 Apr 20;6(4):e009769. doi: 10.1136/bmjopen-2015-009769. 
14. Ravichandran et al. An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients.  Scientific Reports, Apr 2022 (ma preprint in 2021) doi:10.1038/s41598-022-10370-1, CTRI/2021/05/033544
15. Coxib and traditional NSAID Trialists’ (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013 Aug 31;382(9894):769-79. doi: 10.1016/S0140-6736(13)60900-9.
16. Influenza. SIMG: “I farmaci antinfiammatori/Fans comportano diversi rischi: prolungamento della malattia; aumento del rischio di polmoniti; disturbi gastrointestinali; negli anziani ripercussioni sulla funzionalità renale e sull’apparato cardiocircolatorio, rialzi della pressione. Si possono utilizzare (ma non nei primi giorni) per alleviare i sintomi se di chiara natura infiammatoria, ma con cautela, soprattutto in pazienti con problemi gastrointestinali o cardiovascolari”. Quotidiano Sanità, 17-2-2025.